Bausch Health Companies Inc.
BHC.TO
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.05% | 5.25% | 4.60% | 6.13% | 12.16% |
| Total Other Revenue | -14.29% | 8.33% | 33.33% | 19.23% | 12.00% |
| Total Revenue | 6.81% | 5.29% | 4.92% | 6.27% | 12.15% |
| Cost of Revenue | 7.76% | 6.26% | 9.53% | 3.12% | 11.72% |
| Gross Profit | 6.45% | 4.87% | 2.97% | 7.57% | 12.32% |
| SG&A Expenses | -6.47% | 7.45% | 9.25% | 7.09% | 18.88% |
| Depreciation & Amortization | -7.66% | -5.19% | -6.57% | -8.16% | 8.30% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.10% | 4.86% | 5.83% | 3.37% | 12.73% |
| Operating Income | 31.80% | 7.28% | -0.67% | 17.16% | 10.12% |
| Income Before Tax | 1,138.10% | 191.67% | 31.88% | 3,085.71% | 93.56% |
| Income Tax Expenses | -47.89% | -75.51% | 387.50% | 177.50% | 26.79% |
| Earnings from Continuing Operations | 296.74% | 12,900.00% | -11.69% | 308.51% | 75.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -128.57% | 81.82% | 115.38% | -162.50% | 75.00% |
| Net Income | 310.59% | 1,380.00% | 9.38% | 338.46% | 77.51% |
| EBIT | 31.80% | 7.28% | -0.67% | 17.16% | 10.12% |
| EBITDA | 18.13% | 2.69% | -2.75% | 7.78% | 8.93% |
| EPS Basic | 306.63% | 1,366.91% | 10.09% | 327.27% | 77.70% |
| Normalized Basic EPS | 40.57% | -92.33% | 145.30% | 50.78% | 33.67% |
| EPS Diluted | 306.63% | 1,366.91% | 10.09% | 327.27% | 77.70% |
| Normalized Diluted EPS | 40.57% | -92.35% | 145.30% | 50.78% | 33.67% |
| Average Basic Shares Outstanding | 1.93% | 0.82% | 0.76% | 4.92% | 0.82% |
| Average Diluted Shares Outstanding | 1.93% | 0.78% | 0.76% | 4.92% | 0.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |